In order to characterize the poorly defined mechanisms that account for the anti-proteolytic effects of insulin in skeletal muscle, we investigated in rats the effects of a 3 h systemic euglycaemic hyperinsulinaemic clamp on lysosomal, Ca 2 + -dependent proteolysis, and on ubiquitin/proteasome-dependent proteolysis. Proteolysis was measured in incubated fast-twitch mixed-fibre extensor digitorum longus (EDL) and slow-twitch red-fibre soleus muscles harvested at the end of insulin infusion. Insulin inhibited proteolysis (P 0n05) in both muscles. This anti-proteolytic effect disappeared in the presence of inhibitors of the lysosomal/Ca 2 + -dependent proteolytic pathways in the soleus, but not in the EDL, where only the proteasome inhibitor MG 132 (benzyloxycarbonyl-leucyl-leucyl-leucinal) was effective. Furthermore, insulin depressed ubiquitin mRNA levels in the mixed-fibre tibialis anterior, but not in the red-fibre diaphragm muscle, suggesting that insulin inhibits ubiquitin/proteasome-dependent proteolysis in mixedfibre muscles only. However, depressed ubiquitin mRNA levels in such muscles were not associated with significant decreases in the amount of ubiquitin conjugates, or in mRNA levels or protein content for the 14 kDa ubiquitin-conjugating enzyme E2 and 20 S proteasome subunits. Thus alternative, as yet unidentified, mechanisms are likely to contribute to inhibit the ubiquitin/proteasome system in mixed-fibre muscles.
INTRODUCTION
Early in vitro studies clearly indicated that insulin inhibits skeletal muscle protein breakdown [1] [2] [3] . More recent in vivo experiments [4] [5] [6] led to similar conclusions. How-are not responsible for the breakdown of the major contractile proteins (see [8, 9] for recent reviews). By contrast, there is strong and growing evidence that the bulk of overall and myofibrillar muscle protein breakdown is mediated by the ubiquitin (Ub)\proteasome-dependent proteolytic pathway [8, 9] . In brief, the first step in this pathway is the covalent attachment of a polyUb degradation signal to the targeted protein substrate ; this step requires ATP, the Ub-activating enzyme (E1) and one of the Ub-conjugating enzymes (E2) [10] . Most conjugation reactions also require a third enzyme type, known as the Ub-protein ligases (E3), which play a role in substrate recognition. The second step in the Ub\proteasome pathway is the ATP-dependent degradation of polyUb conjugates into peptides by the 26 S proteasome. The 26 S proteasome contains the 20 S proteasome proteolytic core and two 19 S regulatory complexes, which recognize the polyUb degradation signal and then presumably control access of the substrate into the catalytic chamber of the 20 S proteasome [11] .
Previous evidence suggests that insulin inhibits various steps of the Ub\proteasome system in cultured muscle cells. Insulin depressed the mRNA levels for 14 kDa E2 [12] and the activity of the proteasome [13] in L6 myotubes. In contrast, in vivo, hyperinsulinaemia and hyperaminoacidaemia had no effect on 14 kDa E2 expression, but decreased Ub mRNA levels specifically in fast-glycolytic and mixed-fibre skeletal muscles, but not in red-fibre skeletal muscles, from goats [14] . These findings suggest that insulin may affect muscle proteolysis in vivo via mechanisms different from those described in vitro, and that this effect depends on the fibre-type composition. To test these hypotheses further, we investigated for the first time, to our knowledge, the effects of a 3 h hyperinsulinaemic euglycaemic clamp on the lysosomal, Ca# + -dependent, and Ub\proteasome-dependent, proteolytic pathways in rat skeletal muscle. We report here that insulin inhibited Ub\proteasome-dependent proteolysis in the predominantly fast-twitch mixed-fibre extensor digitorum longus (EDL), but not in the slow-twitch red-fibre soleus muscle.
METHODS

Animals and surgery
Young growing male Wistar rats were obtained from Iffa Credo (L'Arbresle, France). Animals were divided randomly into control and insulin-infused groups. They were housed in a temperature-controlled room (22 mC) with a 12-h light\12-h dark cycle, and had free access to water and food. On each experimental day, one control and one insulin-infused rat (mean body weight pS.E.M. 203p4 g ; n l 20) were studied simultaneously after an overnight fast.
General anaesthesia was achieved by an intraperitoneal injection (0.8 ml\100 g body weight) of a 25 % urethane (Sigma Chemical Co., St. Louis, MO, U.S.A.)\saline mixture. Rats underwent surgery to expose the right jugular vein and the carotid artery through a midline neck incision. Polyethylene catheters were inserted into the jugular vein and the carotid artery for insulin or saline (0.9 % NaCl) infusion and blood sampling respectively. The whole procedure took no longer than 30 min. Insulin or saline infusions were started immediately after surgery.
Animal experiments were carried out in accordance with French legislation governing the use of animals, and with NIH guidelines.
Experimental procedures
Control and insulin-infused rats were perfused over a period of 3 h. Insulin-infused rats first received a 1 min infusion of 30 % (w\v) pyrogen-free glucose in saline, administered by a peristaltic pump (LKB). Then a Braun perfusor delivered a primed (0.941p0.093 nmol) constant infusion of human insulin (0.047p0.004 nmol\min) (Actrapid ; Novo Nordisk, Boulogne, France) in saline containing 1 % BSA (Sigma) for 3 h. Glucose was infused together with insulin in order to maintain euglycaemia. The glucose infusion rate was adjusted on the basis of arterial blood glucose concentration, which was measured every 10-15 min using a glucometer (Glucometer 3 ; Bayer Diagnostics). In the control animals, a Braun perfusor delivered the same volume of saline. Plasma insulin was measured in additional blood samples (0.4 ml) drawn at the beginning (time 0) and at the end of the euglycaemic-hyperinsulinaemic clamp in both groups of animals. At the end of the infusion, EDL, soleus, tibialis anterior and diaphragm muscles and liver were excised rapidly. Liver samples and tibialis anterior and diaphragm muscles were rinsed in saline, wiped and frozen in liquid nitrogen.
Rates of proteolysis in skeletal muscle
Soleus and EDL muscles were dissected gently with tendons intact and maintained at resting length on appropriate inert supports. They were preincubated immediately at 37 mC for 20 min in a standard KrebsHenseleit buffer saturated with 95 % O # \5% CO # , as described [15, 16] , but without insulin. The muscles were then transferred into identical fresh medium and incubated for a further 1 h. All muscles were oxygenated continuously with the 95 % O # \5% CO # mixture during the preincubation and incubation periods. Rates of total protein breakdown were measured in the presence of 0.5 mM cycloheximide. Under such conditions, net tyrosine release into the medium is equal to the rate of total protein breakdown [17] . Lysosomal, Ca# + -depend-ent proteolysis was determined by measuring protein breakdown in the presence of 10 mM methylamine and 25 µM leupeptin in a Ca# + -free medium [18] . The potent proteasome inhibitor MG 132 (benzyloxycarbonylleucyl-leucyl-leucinal) [19] was added to the medium at a concentration of 50 µM to determine proteasomedependent proteolysis. Muscle protein content was measured according to the bicinchoninic acid procedure, in order to express all protein breakdown data in units of nmol of Tyr:h −" :mg −" protein. However, since rates of proteolysis varied from day to day, results are presented as percentage of control values.
Analytical methods
Plasma insulin was determined by RIA with an INS-PR kit (CIS BIO International). Tyrosine release was assayed by the fluorimetric method of Waalkes and Udenfriend [20] .
Northern blot analysis
Gene expression was not measured in the incubated EDL or soleus muscles, because the preincubation\incubation itself may alter mRNA levels. In addition, most of the incubations were performed in the presence of inhibitors of proteolysis, and this may also interfere with gene expression measurements. For example, Ub mRNA showed increased stability in muscles incubated in the presence of the proteasome inhibitor N-acetyl-Lleucinyl-L-leucinal-L-norleucinal [21] . Thus gene expression was measured in the tibialis anterior and diaphragm muscles. The tibialis anterior contains mainly fast-twitch mixed fibres, like the EDL [22] , and diaphragm contains predominantly slow-twitch red fibres, like the soleus [23] . Total RNA was extracted from muscles and liver as described [14] [15] [16] . Samples of 20 µg of total RNA were separated in a formaldehyde\agarose gel (1 %), transferred electrophoretically to nylon membranes (GeneScreen ; NEN, Boston, MA, U.S.A.), and bound covalently to the membranes by UV cross-linking. Membranes were hybridized with cDNA probes encoding chicken polyUb, rat 14 kDa E2, rat C2 and C5 20 S proteasome subunits, human m-calpain and cathepsin D, and rat phosphoenolpyruvate carboxykinase (PEPCK). Hybridizations were conducted overnight at 65 mC with $#P-labelled cDNA fragments labelled by random priming, as described previously [14] [15] [16] . Following washings at the same temperature, filters were autoradiographed at k80 mC with intensifying screens on Hyperfilm-MP (Amersham). After stripping of the different probes, the membranes were re-probed with a $#P-labelled cDNA encoding the mouse 18 S rRNA that was used to correct for slightly unequal loading of RNA. All samples of liver or muscle were run on the same gel. 
Western blot analysis
Tibialis anterior muscles were homogenized in 20 vol. of a buffer (2.5 mM Tris, 1 mM dithiotreitol and 5 mM EDTA, pH 7.5) containing a protease inhibitor (2 mM PMSF ; Sigma Chemical Co.). The protein content of the homogenate was determined using a Bio-Rad assay. Samples of 75 µg of muscle protein were separated by SDS\PAGE and transferred electrophoretically on to nylon membranes. Membranes were blocked in 5 % (w\v) dried milk in 1iTTNS (25 mM Tris, pH 7.5, 0.1 % Tween and 0.9 % NaCl) at room temperature for 2 h. After three washings in 1iTTNS, membranes were hybridized with antibodies against Ub, 14 kDa E2, and the 27 kDa Iota and 26 kDa Zeta subunits of the 20 S proteasome. The antibody against Ub was purchased from Sigma Chemical Co., the antibody against 14 kDa E2 was kindly provided by Dr Simon S. Wing (McGill University, Montre! al, Canada), and the monoclonal antibodies against the Iota and Zeta subunits of the 20 S proteasome were kindly provided by Dr Hans-Peter Schmid (University Blaise Pascal, Clermont-Ferrand, France). After being washed at room temperature, the membranes were hybridized with the appropriate peroxidase-conjugated anti-IgG. Membranes were washed four times in 1iTTNS, and peroxidase activity was detected using an ECL2 kit (Amersham).
Statistics
Results are given as meanspS.E.M. for n l 5 rats per group. The significance of differences was analysed by Student's t test. A value of P 0.05 was taken as statistically significant.
RESULTS
Plasma insulin and glucose
The basal plasma insulin concentration was 0.38p0.07 and 0.33p0.02 nmol\l in control and insulin-infused rats respectively at time 0 (before infusion). At the end of the infusions, plasma insulin remained similar to basal levels in control rats (0.33p0.05 nmol\l), but was significantly higher in insulin-infused rats (19.36p2.35 nmol\l; P 0.001 compared with control rats at 3 h and with insulininfused animals at time 0).
The basal glucose concentration was 6.57p0.68 and 8.40p0.43 mmol\l in the control and insulin-infused groups respectively. These values are slightly high for rats that have been starved for one night. This was presumably due to surgical stress, since the basal glucose concentration was measured only a few minutes after surgery. Nevertheless, in pilot studies using control rats, plasma glucose was approx. 5-6 mmol\l at the end of a 3 h saline Rates of protein breakdown were measured without inhibitors (A ; total rates of proteolysis), or in the presence of inhibitors of the lysosomal and Ca 2 + -dependent pathways (B) or of the proteasome inhibitor MG 132 (C), as described in the Methods section. On each experimental day, one control and one insulin-infused rat were studied simultaneously. On an absolute basis, the lysosomal/Ca 2 + -dependent and the proteasome-dependent components contributed " 25 % and 40 % of total proteolysis respectively, whatever the muscle type. However, since rates of proteolysis varied from day to day, values for insulin-infused rats (closed bars) are expressed as a percentage of those for control animals (open bars) ; values are meanspS.E.M. for five rats. Significance of differences : *P 0.05 compared with control values.
infusion. Therefore we chose to maintain blood glucose around this value, and plasma glucose concentrations were 5.39p0.39 and 6.05p0.24 mmol\l (P 0.05) at the end of the infusions in the control and insulin-infused animals respectively. Plasma glucose was maintained approximately constant in the insulin-infused rats ; the mean coefficient of variation was 13.6 % over the 0-3 h period (results not shown).
Rates of skeletal muscle proteolysis
Insulin infusion inhibited total protein breakdown (P 0.05) by 31 % and 23 % in the EDL and soleus muscle respectively (Figure 1 ). In the presence of inhibitors of the lysosomal and Ca# + -dependent proteolytic pathways, the rate of total proteolysis in the EDL was still 34 % lower (P 0.05) in insulin-infused rats than in controls. In contrast, the inhibitors of lysosomal and Ca# + -dependent proteolysis abolished the decrease in the rate of total protein breakdown that was observed in the soleus of insulin-infused rats (P 0.05). Finally, the proteasome inhibitor MG 132 totally suppressed the decrease in total protein breakdown seen in the EDL 
mRNA levels for PEPCK in liver and for proteolysis-associated genes in skeletal muscle
In accordance with the well known effect of insulin on the transcription of PEPCK [24] , hyperinsulinaemia decreased the mRNA levels for that gene in the liver (results not shown), demonstrating that our experimental model was appropriate to study the regulation of gene expression by insulin in vivo. Both cathepsin D and mcalpain mRNA levels were unaffected by insulin infusion in the diaphragm and tibialis anterior (Figure 2 ). Insulin caused a significant reduction (P 0.05) in Ub mRNA levels in the tibialis anterior, but not in the diaphragm. In contrast, the mRNA levels for 14 kDa E2 and subunits C2 and C5 of the 20 S proteasome were unaltered by hyperinsulinaemia in both muscles (Figure 2) . Samples of 75 µg of muscle proteins were separated by SDS/PAGE and transferred electrophoretically to a nylon membrane. The membranes were first hybridized with an antibody against Ub. After washing, the membranes were hybridized with appropriate peroxidase-conjugated anti-IgG, and peroxidase activity was detected by chemiluminescence. Membranes were then stained with Coomassie Blue, and the amount of 91 kDa α-actinin in each lane was determined by densitometric scanning. Representative Western blots are shown for two control (C) and two insulin-infused (I) rats. Values for densitometric quantification of the major Ub conjugates (corrected for α-actinin abundance) in the insulin-infused animals are expressed as a percentage of those in control rats ; values are meanspS.E.M. for five rats. No significant effect of insulin was detected (P 0.05). Samples of 75 µg of muscle protein were separated by SDS/PAGE and transferred electrophoretically to nylon membranes. Membranes were first hybridized with antibodies against the 26 kDa Zeta subunit or the 27 kDa Iota subunit of the 20 S proteasome, or against 14 kDa E2. After washing, the membranes were hybridized and stained as described in the legend to Figure 3 . Representative Western blots are shown for two control (C) and two insulin-infused (I) rats. Values for densitometric quantification of the signals (corrected for α-actinin abundance) in the insulin-infused animals are expressed as a percentage of those in control rats ; values are meanspS.E.M. for five rats. No significant effect of insulin was detected (P 0.05).
Ub conjugates and protein content of 14 kDa E2 and 20 S proteasome subunits in muscle
The amounts of the most abundant Ub conjugates (63, 41, 39 and 33 kDa) were slightly but not significantly decreased in the tibialis anterior muscle from insulininfused rats compared with that from controls ( Figure 3) . Western blot analyses also revealed that the amounts of 14 kDa E2 and of the Iota (27 kDa) and Zeta (26 kDa) 20 S proteasome subunits were not altered by insulin infusion (Figure 4) .
DISCUSSION
The present study provides evidence that hyperinsulinaemia inhibits protein breakdown in mixed-and red-fibre muscles via distinct mechanisms. The antiproteolytic effect of the hormone was suppressed in the presence of inhibitors of the lysosomal and Ca# + -dependent proteolytic pathways in the soleus, but not in the EDL (Figure 1) . In contrast, the proteasome inhibitor MG 132 abolished the anti-proteolytic effect of insulin in the mixed-fibre EDL, but not in the red-fibre soleus (Figure 1) . Furthermore, in vivo, insulin down-regulated the expression of Ub in mixed-fibre muscles only ( Figure  2 ), suggesting that insulin specifically inhibits Ub\ proteasome-dependent proteolysis in fast-twitch skeletal muscles.
This interpretation requires (1) that the in vitro incubation system measures proteolysis that is representative of the in vivo response, and (2) that gene expression in the tibialis anterior and diaphragm is representative of the changes in the EDL and soleus respectively. However, our findings are supported by several previous observations. We have reported previously that hyperinsulinaemia and hyperaminoacidaemia depressed Ub mRNA levels only in white-or mixed-fibre muscles in goats [14] . Hyperinsulinaemia and hyperaminoacidaemia strongly inhibit whole-body protein breakdown in such conditions [25] . This suggested that a possible antiproteolytic effect of the hormone on the Ub\proteasome pathway in the musculature (which comprises mainly fast-twitch mixed-fibre muscles) may contribute to the reduced proteolysis at the whole-body level [14] . However, it was not possible in these previous experiments to measure rates of skeletal muscle proteolysis. Furthermore, the effect of insulin was confounded by hyperaminoacidaemia, which may itself have a suppressive effect on proteolysis and potentiate the effect of insulin [26] . We now show that hyperinsulinaemia alone depressed Ub expression concomitantly with the inhibition of a non-lysosomal, Ca# + -independent but proteasome-dependent proteolytic process in mixedfibre muscles. First, this observation is in good agreement with the postabsorptive insulin-induced inhibition of a non-lysosomal proteolytic process in human skeletal muscle [27] . Furthermore, insulinopaenia activates a non-lysosomal, Ca# + -independent but ATP-and Ub\ proteasome-dependent proteolytic pathway in rat fasttwitch skeletal muscles [28] [29] [30] . Secondly, insulinopaenia only stimulated ATP-independent but Ca# + -dependent proteolysis in the soleus muscle [28] . Conversely, we report in the present study that the insulin-induced suppression of proteolysis only disappeared in the presence of inhibitors of the lysosomal and Ca# + -dependent proteases in the soleus (Figure 1) . Finally, except in non-weight-bearing animals [16] , muscle atrophy is much more pronounced in mixed-fibre than in red-fibre muscles in many catabolic states, including diabetes [28] , sepsis [31] , cancer [18] , glucocorticoid administration [32] and fasting [33] , and reflects a limited activation (when any ; see [31] ) of the proteasome system in red-fibre muscles. The poor responsiveness of such muscles to various stresses and hormonal regulation (e.g. by hypoinsulinaemia in fasting [33] and by hyperinsulinaemia in the present study) presumably serves to maintain the integrity of vital postural and respiratory functions that are performed by slow-twitch muscles.
The increased transcription and\or mRNA levels of Ub in atrophying muscles from both cachectic animals (reviewed in [8, 9] ) and weight-losing patients [34, 35] strongly suggest that the amount of free Ub may become rate limiting for substrate ubiquitination. It has been postulated that the intracellular concentration of free Ub might be driving the Ub system [36] . Therefore we investigated whether the reduced expression of Ub in mixed-fibre muscles following hyperinsulinaemia resulted in depressed amounts of Ub conjugates, but Figure  3 shows that this was not the case. Alternatively, Wing and Banville [12] suggested that substrate ubiquitination by 14 kDa E2 was a potential rate-limiting step in muscle. This major mammalian E2 interacts with the N-end rule E3α and conjugates Ub to soluble muscle proteins [37] . Its 1.2 kb transcript is up-regulated in various instances of muscle atrophy in both animal models [12, 15, 16, [38] [39] [40] and humans [34] . In addition, insulin down-regulated the expression of 14 kDa E2 in L6 myotubes [12] . However, we failed to detect any reduction in mRNA levels for 14 kDa E2 in rat skeletal muscle following hyperinsulinaemia, as reported in vivo in goats [14] , or in the muscle content of this enzyme (Figure 4) .
The accumulation of ubiquitinated proteins observed in muscles from fasted, denervated [41] or tumourbearing [18] rats argues strongly that the peptidase and\or proteolytic activities of the proteasome could be rate limiting in the pathway. Furthermore, an increased expression of 20 S proteasome subunits is correlated systematically with enhanced muscle proteolysis in all catabolic states so far studied [8, 9] . Increased mRNA levels for several 20 S proteasome subunits in atrophying rodent muscles are correlated with increased abundance of the 27 kDa Iota subunit [18] and increased chymotrypsin-like and peptidylglutamyl peptidase activities of the 20 S proteasome [31] . These mRNAs are actively transcribed [16] or reflect enhanced transcription [30] . Unfortunately, we failed to demonstrate any significant decreases in mRNA levels (Figure 2 Several alternative mechanisms may contribute to an insulin-induced inhibition of the proteasome system. For example, phosphorylation and dephosphorylation reactions are extremely important in mediating the intracellular effects of insulin. The inhibition of skeletal muscle proteolysis by insulin requires activation of phosphatidylinositol 3-kinase [42] , which initiates a phosphorylation cascade. In addition, the labelling of many substrates of the Ub pathway [43] , and the activities of E1 [44] , some E2 enzymes (e.g. Ubc3 ; see [45] ) and E3 (e.g. phosphoprotein-Ub ligase complexes ; see [10, 43] ) depend on their phosphorylation status. Subunits C8 and C9 of the 20 S proteasome [46, 47] and several ATPase subunits of the 19 S complex [48] are also phosphorylated. Insulin may potentially affect the phosphorylation pattern of such proteins, which in turn could result in altered Ub conjugation and\or proteasome activities. Alternatively, one cannot rule out the possibility that insulin may have a direct effect on proteasomes through the insulin-degrading enzyme [13] and\or changes in proteasome conformation [49] . However, further investigations are clearly needed to obtain evidence in support of these hypotheses.
